Update on pediatric cancer predisposition syndromes

Pediatric Blood and Cancer

Volumn 60, Issue 8, 2013, Pages 1247-1252

  Schiffman, Joshua D ^a   Geller, James I ^b   Mundt, Erin ^b   Means, Anthony ^a   Means, Lindsey ^a   Means, Von ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

DICER1; Genetic testing; Hereditary cancer syndrome; Li Fraumeni Syndrome; Paraganglioma; SDH

Indexed keywords

ANDROBLASTOMA; BECKWITH WIEDEMANN SYNDROME; BILATERAL CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHILDHOOD CANCER; CLINICAL DECISION MAKING; CONFERENCE PAPER; EARLY DIAGNOSIS; EMBRYONAL RHABDOMYOSARCOMA; ETHICS; FAMILIAL CANCER; FAMILY HISTORY; FERTILIZATION IN VITRO; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOME; HAMARTOMA; HEMATOLOGIST; HUMAN; INCIDENTAL FINDING; INHERITANCE; LUNG BLASTOMA; MALIGNANT TRANSFORMATION; MEDICAL SPECIALIST; MULTIPLE CANCER; MULTIPLE ENDOCRINE NEOPLASIA; NEURILEMOMA; NEUROECTODERM TUMOR; NEUROEPITHELIOMA; NEUROFIBROMATOSIS; ONCOLOGIST; PARAGANGLIOMA; PEUTZ JEGHERS SYNDROME; PHENOTYPE; PHEOCHROMOCYTOMA; PHYSIOTHERAPY; PLASTIC SURGERY; PRIORITY JOURNAL; RELIGION; RETINOBLASTOMA; RHABDOID TUMOR; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; BIOETHICS; CHILD; CHILD, PRESCHOOL; CONGRESSES AS TOPIC; EDUCATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; LI-FRAUMENI SYNDROME; MALE; NEOPLASMS; SOCIETIES, MEDICAL; SYNDROME; UNITED STATES;

EID: 84879225075     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24555     Document Type: Conference Paper

References (48)

1. Koocher GP, O'Malley JE. The Damocles syndrome: Psychosocial consequences of surviving childhood cancer. New York: McGraw-Hill; 1981. xx, 219 p.
2. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467:1114-1117.
3. Aktipis CA. Know when to walk away: Contingent movement and the evolution of cooperation. J Theor Biol 2004; 231:249-260.
4. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 2005; 23:276-292.
5. Knapke S, Nagarajan R, Correll J, et al. Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatr Blood Cancer 2012; 58:85-89.
6. Schiffman JD. Hereditary cancer syndromes: If you look, you will find them. Pediatr Blood Cancer 2012; 58:5-6.
7. Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 1969; 71:747-752.
8. Tinat J, Bougeard G, Baert-Desurmont S, et al. 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 2009; 27:e108-e109; author reply e110.
9. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233-1238.
10. Villani A, Tabori U, Schiffman J, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: A prospective observational study. Lancet Oncol 2011; 12:559-567.
11. Strahm B, Malkin D. Hereditary cancer predisposition in children: Genetic basis and clinical implications. Int J Cancer J Int du Cancer 2006; 119:2001-2006.
12. S . K, K . Z, K.E . N, et al. Identification, Management, and Evaluation of Children with Cancer-Predisposition Syndromes 2012.
13. Janson K, Nedzi LA, David O, et al. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation. Pediatr Blood Cancer 2006; 47:279-284.
14. Bruggers CS, Bleyl SB, Pysher T, et al. Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer 2011; 56:1026-1031.
15. Rousseau G, Noguchi T, Bourdon V, et al. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. BMC Neurol 2011; 11:9.
16. Eaton KW, Tooke LS, Wainwright LM, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 2011; 56:7-15.
17. Geller JI, Leslie ND, Yin H. 2012 February 20, 2013. Malignant Rhabdoid Tumor. . February 20, 2013.
18. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 2011; 43:663-667.
19. Burnichon N, Cascon A, Schiavi F, et al. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clinical Cancer Res 2012; 18:2828-2837.
20. Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): Molecular genetics and clinical implications. J Intern Med 2009; 266:43-52.
21. Buffet A, Venisse A, Nau V, et al. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma. Horm Metab Res 2012; 44:359-366.
22. King KS, Prodanov T, Kantorovich V, et al. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: Significant link to SDHB mutations. J Clin Oncol 2011; 29:4137-4142.
23. Schiffman JD. No child left behind in SDHB testing for paragangliomas and pheochromocytomas. J Clin Oncol 2011; 29:4070-4072.
24. Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, et al. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer 2009; 16:391-400.
25. Jasperson KW, Kohlmann W, Gammon A, Slack H, Buchmann L, Hunt J, Kirchhoff AC, Baskin H, Shaaban A, Schiffman JD. Role of Rapid Sequence Whole-Body MRI Screening in SDH-Associated Hereditary Paraganglioma Families. Fam Cancer (In press).
26. Hill DA, Ivanovich J, Priest JR, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009; 325:965.
27. Foulkes WD, Bahubeshi A, Hamel N, et al. Extending the phenotypes associated with DICER1 mutations. Hum Mutat 2011; 32:1381-1384.
28. Slade I, Bacchelli C, Davies H, et al. DICER1 syndrome: Clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet 2011; 48:273-278.
29. Rio Frio T, Bahubeshi A, Kanellopoulou C, et al. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA 2011; 305:68-77.
30. Loeb LA. Human cancers express mutator phenotypes: Origin, consequences and targeting. Nat Rev Cancer 2011; 11:450-457.
31. Bielas JH, Loeb KR, Rubin BP, et al. Human cancers express a mutator phenotype. Proc Natl Acad Sci USA 2006; 103:18238-18242.
32. American Thyroid Association Guidelines, Task F, Kloos RT, Eng C, et al. Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid 2009; 19:565-612.
33. Lwiwski N, Greenberg CR, Mhanni AA. Genetic testing of children at risk for adult onset conditions: When is testing indicated? J Genet Counsel 2008; 17:523-525.
34. Debaun MR. December 14, 2012. Screening protocol for Beckwith-Wiedemann syndrome . December 14, 2012.
35. Mai PL, Malkin D, Garber JE, et al. Li-Fraumeni syndrome: Report of a clinical research workshop and creation of a research consortium. Cancer Genet 2012; 205:479-487.
36. Rechitsky S, Verlinsky O, Chistokhina A, et al. Preimplantation genetic diagnosis for cancer predisposition. Reprod Biomed Online 2002; 5:148-155.
37. Simpson JL, Carson SA, Cisneros P. Preimplantation genetic diagnosis (PGD) for heritable neoplasia. J Natl Cancer Inst Monogr 2005; 87-90. Review. PubMed PMID: 15784832.
38. Offit K, Kohut K, Clagett B, et al. Cancer genetic testing and assisted reproduction. J Clin Oncol 2006; 24:4775-4782.
39. Xu K, Rosenwaks Z, Beaverson K, et al. Preimplantation genetic diagnosis for retinoblastoma: The first reported liveborn. Am J Ophthalmol 2004; 137:18-23.
40. Solomon BD, Hadley DW, Pineda-Alvarez DE, et al. Incidental medical information in whole-exome sequencing. Pediatrics 2012; 129:e1605-1611.
41. Lemke A, Bick D, Dimmock D, et al. Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: A survey study. Clinical genetics 2012. Nov 20. doi: 10.1111/cge.12060 [Epub ahead of print] PubMed PMID: 23163796.
42. Wolf SM, Lawrenz FP, Nelson CA, et al. Managing incidental findings in human subjects research: Analysis and recommendations. J Law Med Ethics 2008; 36:219-248, 211.
43. Townsend A, Adam S, Birch PH, et al. " I want to know what's in Pandora's Box": Comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing. Am J Med Genet A 2012; 158A:2519-2525.
44. Caga-anan EC, Smith L, Sharp RR, et al. Testing children for adult-onset genetic diseases. Pediatrics 2012; 129:163-167.
45. O'Neill SC, Peshkin BN, Luta G, et al. Primary care providers' willingness to recommend BRCA1/2 testing to adolescents. Fam Cancer 2010; 9:43-50.
46. Malpas PJ. Why tell asymptomatic children of the risk of an adult-onset disease in the family but not test them for it? J Med Ethics 2006; 32:639-642.
47. Malpas PJ. Predictive genetic testing of children for adult-onset diseases and psychological harm. J Med Ethics 2008; 34:275-278.
48. Simon C, Shinkunas LA, Brandt D, et al. Individual genetic and genomic research results and the tradition of informed consent: Exploring US review board guidance. J Med Ethics 2012; 38:417-422.